Comments

  • TSI Editorial Team 

    This is truly one of the great American companies. I’ve been a shareholder for years and will continue to be. I understand what you’re saying though, Pat, about the challenges of bringing new drugs to market. I believe JNJ can continue to manage that process. Thanks for your insights.

  • I’ve also held J&J for years. Was thinking about picking up some more, but I think I’ll heed your advice and hold off for now.

  • Robert 

    I think the hold is “good” advice for the majority of the large drug companies until the election uncertainties are over and the threats of political action on prices end with it.

Tell Us What YOU Think

You must be logged in to post a comment.

Please be respectful with your comments and help us keep this an area that everyone can enjoy. If you believe a comment is abusive or otherwise violates our Terms of Use, please click here to report it to the administrator.